Cohen Capital Management, Inc. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 198 filers reported holding HERON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cohen Capital Management, Inc. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$3,345,000
+27.0%
142,3300.0%0.72%
+19.8%
Q3 2019$2,633,000
-0.5%
142,3300.0%0.60%
-1.9%
Q2 2019$2,646,000
-23.6%
142,330
+0.4%
0.62%
-26.1%
Q1 2019$3,465,000
-5.8%
141,7800.0%0.84%
-18.0%
Q4 2018$3,678,000
-17.6%
141,780
+0.6%
1.02%
+1.3%
Q3 2018$4,463,000
-18.4%
141,000
+0.2%
1.00%
-20.6%
Q2 2018$5,467,000
+23.8%
140,710
+0.5%
1.27%
+22.0%
Q1 2018$4,417,000140,0001.04%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders